Lost Art Liquids is the second vaping company to go on record with a lawsuit against the Food and Drug Administration. They filed earlier this week in the Central District of California, challenging the “purported authority to ”deem and regulate e-liquids and other vapor products as ‘tobacco products’ under the Tobacco Control Act and asserts claims against FDA for violations of the Regulatory Flexibility Act, the 1st and 5th Amendments, and the Administrative Procedures Act,” according to a release on PRNewswire.com.
“Lost Art Liquids is and has always been committed to producing the highest quality, safest, and most innovative premium e-liquid products and in serving as a voice for the vapor community. FDA, with its deeming regulation, has ignored our voice and the voices of millions of others, leaving us no choice but to seek judicial relief,” Brian Worthy, CEO of Lost Art Liquids, said in the release. “We are disappointed that the FDA continues to confuse and conflate vapor products with tobacco and chooses to ignore years of well-established research that shows the relative safety of the products compared to combustible cigarettes and the public health benefit they may offer to millions of Americans who use them as an alternative to tobacco.”
Lost Art Liquids argues that the regulation by the FDA is illegal, asserting that vapor products are technology products, not tobacco products.
For the full release, visit http://www.prnewswire.com/news-releases/lost-art-liquids-llc-files-lawsuit-against-fda-300272069.html.